IPP Bureau
EPR-Technologies announces new approach to emergency care when CPR fails
By IPP Bureau - June 16, 2022
EPR-Technologies is pursuing development of an unprecedented standard of emergency care when CPR fails
CytoSMART introduces ML algorithm for organoid analysis
By IPP Bureau - June 16, 2022
The innovative software module is designed to meet growing scientific demand from researchers and drug developers
Merck KGaA collaborates with University of Bonn to advance molecular machine learning
By IPP Bureau - June 15, 2022
The three-year collaboration will focus on the development of new tools for computational chemistry modelling as well as new molecular representations to advance the next generation of molecular machine learning
Dr. Reddy's Lab launches sorafenib tablets in US
By IPP Bureau - June 15, 2022
Dr. Reddy's Sorafenib Tablets, USP, are available in 200 mg tablets in bottle count sizes of 120.
Cipla and DNDi launch child-friendly 4-in-1 antiretroviral treatment for HIV in South Africa
By IPP Bureau - June 15, 2022
This new formulation represents a significant improvement over protease inhibitor-containing paediatric ARV formulations that have been used in South Africa for decades.
Piramal Pharma expands API capabilities at Digwal
By IPP Bureau - June 15, 2022
Site has a capital investment program of ~$30 million spent or committed over the last three years to expand capabilities and improve operational efficiencies
Eurocine Vaccines expands portfolio with a therapeutic HSV-2 vaccine candidate
By IPP Bureau - June 15, 2022
Redbiotec has a right to royalties on Eurocine Vaccines´ net sales of an approved HSV-2 vaccine, should such sales arise.
ADC Therapeutics appoints David Gilman as Chief Business & Strategy Officer
By IPP Bureau - June 15, 2022
Gilman will be responsible for all business development and portfolio strategy efforts globally.
Eli Lilly gets FDA approval for alopecia drug
By IPP Bureau - June 15, 2022
Alopecia areata usually presents as a few small bald patches in the head
InfuSystem and Ventis ink sales agreement for pain management
By IPP Bureau - June 15, 2022
The company will offer Ventis Pharma’s patented local anesthetic compound, Endura-KitTM for post-operative surgical and chronic pain management
Etihad Cargo signs MOU for sustainable pharmaceutical transportation solutions
By IPP Bureau - June 15, 2022
Becomes the first airline globally to develop and launch sustainable, temperature-controlled containers for the transportation of pharmaceuticals
CCI approves sale of biosimilars portfolio of Viatris to Biocon Biologics
By IPP Bureau - June 15, 2022
The proposed transaction involves the sale of the global biosimilars portfolio of Viatris to Biocon Biologics
CCI approves acquisition of corporate restructuring of GlaxoSmithKline Consumer Healthcare
By IPP Bureau - June 15, 2022
The proposed combination involves corporate restructuring of JVCO, including through acquisition by Haleon via demerger
NHA and NASSCOM organised a conclave on Ayushman Bharat Digital Mission
By IPP Bureau - June 15, 2022
The Ayushman Bharat Digital Mission (ABDM) aims to replicate this success in healthcare delivery by building an equitable, accessible and inclusive ecosystem
COVID is not over yet, says Union Health Minister
By IPP Bureau - June 14, 2022
Increased and timely testing will enable early identification of COVID cases and help to curb spread of the infection among the community
